Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition

Benzinga_recent_news

Yesterday

• Regeneron Pharmaceuticals stock is facing resistance. Why are REGN shares declining? AFRS is a condition characterized by allergic hypersensitivity to fungi, which often leads to chronic sinus ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2614744498"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614744498\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614744498?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/24/Blue-3d-Graphic-Of-A-Woman-With-Sinus-Pa.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-02-25 02:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614744498","market":"us","top_or_hot":-1,"title":"Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition","media":"Benzinga_recent_news","content":"<div>\n<p>• Regeneron Pharmaceuticals stock is facing resistance. Why are REGN shares declining?\nAFRS is a condition characterized by allergic hypersensitivity to fungi, which often leads to chronic sinus ...</p>\n\n<a href=\"https://www.benzinga.com/news/fda/26/02/50827647/regeneron-sanofi-blockbuster-dupixent-scores-fda-nod-for-rare-sinus-condition\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-25 02:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/fda/26/02/50827647/regeneron-sanofi-blockbuster-dupixent-scores-fda-nod-for-rare-sinus-condition><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>• Regeneron Pharmaceuticals stock is facing resistance. Why are REGN shares declining?\nAFRS is a condition characterized by allergic hypersensitivity to fungi, which often leads to chronic sinus ...</p>\n\n<a href=\"https://www.benzinga.com/news/fda/26/02/50827647/regeneron-sanofi-blockbuster-dupixent-scores-fda-nod-for-rare-sinus-condition\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNYNF","symbol_name":"Sanofi","start_time":0,"source_url":"https://www.benzinga.com/news/fda/26/02/50827647/regeneron-sanofi-blockbuster-dupixent-scores-fda-nod-for-rare-sinus-condition","article_id":"2614744498","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/24/Blue-3d-Graphic-Of-A-Woman-With-Sinus-Pa.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/26/02/50827647/regeneron-sanofi-blockbuster-dupixent-scores-fda-nod-for-rare-sinus-condition","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614744498","pubTimestamp":1771958820,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"FDA approves Regeneron and Sanofi's Dupixent for allergic fungal sinusitis in patients 6 years and older with prior surgery history.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SNYNF":"Sanofi","SMA":"Smartstop Self Storage REIT Inc","BK4007":"制药","BK4217":"自存仓储房地产信托"},"translate_title":"再生元(Regeneron)和赛诺菲(Sanofi)重磅炸弹Dupixent因罕见鼻窦疾病获得FDA批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNYNF":1.5,"SMA":1},"content_text":"• Regeneron Pharmaceuticals stock is facing resistance. Why are REGN shares declining?\nAFRS is a condition characterized by allergic hypersensitivity to fungi, which often leads to chronic sinus issues and surgery.\nThe approval covers Dupixent for patients aged six years and older with a history of sino-nasal surgery.\nThe approval is based on Phase 3 trial results that demonstrated Dupixent’s effectiveness in reducing nasal symptoms and the need for systemic corticosteroids or surgery compared to placebo.\nDupixent is now approved for nine distinct diseases driven by type 2 inflammation, including chronic rhinosinusitis with nasal polyps.\nCurrently, the stock is trading 5.2% below its 20-day simple moving average (SMA) and 8.4% below its 100-day SMA, indicating short-term weakness. Over the past 12 months, shares have increased approximately 64%, and they are currently positioned closer to their 52-week highs than lows, reflecting a generally positive long-term trend.\nThe RSI is at 50.00, which is considered neutral territory, suggesting the stock is neither overbought nor oversold. Meanwhile, MACD is at 0.10, below its signal line at 0.15, indicating bearish pressure on the stock.\nThe combination of neutral RSI and bearish MACD suggests mixed momentum, indicating that traders should watch for potential shifts in market sentiment.\nAnalyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $819.70. Recent analyst moves include:\nREGN Price Action: Regeneron Pharmaceuticals shares were down 0.77% at $781.01 at the time of publication on Tuesday, according to Benzinga Pro data.\nPhoto: Shutterstock AI Generator\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}